Taipei Times
Date: Aug 09, 2019
By: Sherry Hsiao  /  Staff writer, with CNA

Researchers from National Chiao Tung University (NCTU) and Taipei Medical University (TMU) yesterday said they discovered that the antidepressant bupropion can be used as an anti-metastasis drug for triple-negative breast cancer.

Cell and animal experiments have confirmed the finding, an NCTU team said at a news conference in Hsinchu, where the school is based.

Researchers are in the process of applying for patents in several countries, they added.

Biopsies of cancer cells and tissues confirm that nicotine receptors and human epidermal growth factor receptor 2 (HER2) proteins form close connections, a TMU team said.    [FULL  STORY]